1. Home
  2. KLTOW vs EML Comparison

KLTOW vs EML Comparison

Compare KLTOW & EML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • EML
  • Stock Information
  • Founded
  • KLTOW N/A
  • EML 1858
  • Country
  • KLTOW United States
  • EML United States
  • Employees
  • KLTOW 3
  • EML N/A
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • EML Industrial Machinery/Components
  • Sector
  • KLTOW Health Care
  • EML Consumer Discretionary
  • Exchange
  • KLTOW Nasdaq
  • EML Nasdaq
  • Market Cap
  • KLTOW N/A
  • EML 144.0M
  • IPO Year
  • KLTOW 2022
  • EML N/A
  • Fundamental
  • Price
  • KLTOW $0.25
  • EML $24.46
  • Analyst Decision
  • KLTOW
  • EML
  • Analyst Count
  • KLTOW 0
  • EML 0
  • Target Price
  • KLTOW N/A
  • EML N/A
  • AVG Volume (30 Days)
  • KLTOW N/A
  • EML 12.1K
  • Earning Date
  • KLTOW N/A
  • EML 08-05-2025
  • Dividend Yield
  • KLTOW N/A
  • EML 1.80%
  • EPS Growth
  • KLTOW N/A
  • EML N/A
  • EPS
  • KLTOW N/A
  • EML N/A
  • Revenue
  • KLTOW N/A
  • EML $271,440,503.00
  • Revenue This Year
  • KLTOW N/A
  • EML $1.56
  • Revenue Next Year
  • KLTOW N/A
  • EML $7.00
  • P/E Ratio
  • KLTOW N/A
  • EML $11.55
  • Revenue Growth
  • KLTOW N/A
  • EML 8.15
  • 52 Week Low
  • KLTOW N/A
  • EML $19.06
  • 52 Week High
  • KLTOW N/A
  • EML $35.03
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW N/A
  • EML 62.18
  • Support Level
  • KLTOW N/A
  • EML $24.04
  • Resistance Level
  • KLTOW N/A
  • EML $24.70
  • Average True Range (ATR)
  • KLTOW 0.00
  • EML 0.55
  • MACD
  • KLTOW 0.00
  • EML 0.13
  • Stochastic Oscillator
  • KLTOW 0.00
  • EML 91.74

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About EML Eastern Company (The)

The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.

Share on Social Networks: